ResearcherHunan Normal UniversityActive in the last 2 years

Shasha Fan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8180-2624; OpenAlex author ID A5044934387. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

One- and two-year overall survival following stereotactic body radiotherapy versus conventional radiotherapy for pancreatic cancer: a systematic review and met… Co-author DOI 10.1097/js9.0000000000003992 ↗
Survival benefit of radiotherapy in pancreatic cancer A real-world analysis based on SEER and an independent hospital-based cohort. Last author DOI 10.1097/js9.0000000000004098 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lin Zhang · 2 shared papers, 2025–2026 · strength 0.60
- Paper One- and two-year overall survival following stereotactic body radiotherapy versus conventional radiotherapy for pancre… DOI 10.1097/js9.0000000000003992 ↗
- Paper Survival benefit of radiotherapy in pancreatic cancer A real-world analysis based on SEER and an independent hospital-b… DOI 10.1097/js9.0000000000004098 ↗
Mengqi Yang · 1 shared paper, 2026 · strength 0.32
- Paper One- and two-year overall survival following stereotactic body radiotherapy versus conventional radiotherapy for pancre… DOI 10.1097/js9.0000000000003992 ↗
Yanglong Ou · 1 shared paper, 2025 · strength 0.28
- Paper Survival benefit of radiotherapy in pancreatic cancer A real-world analysis based on SEER and an independent hospital-b… DOI 10.1097/js9.0000000000004098 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.